BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30484407)

  • 1. Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.
    Maiese K
    Curr Neurovasc Res; 2018; 15(4):367-371. PubMed ID: 30484407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
    Maiese K
    Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
    Maiese K
    Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
    Maiese K
    J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
    Maiese K
    Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
    Maiese K
    Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease.
    Maiese K
    J Transl Sci; 2016; 1(3):83-85. PubMed ID: 26893943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
    Maiese K
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
    [No Abstract]   [Full Text] [Related]  

  • 11. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
    Maiese K
    Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
    Maiese K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease.
    Maiese K
    Neural Regen Res; 2015 Apr; 10(4):518-28. PubMed ID: 26170801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
    Maiese K
    Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programming apoptosis and autophagy with novel approaches for diabetes mellitus.
    Maiese K
    Curr Neurovasc Res; 2015; 12(2):173-88. PubMed ID: 25742566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.
    Maiese K
    World J Stem Cells; 2015 Mar; 7(2):235-42. PubMed ID: 25815111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell guidance through the mechanistic target of rapamycin.
    Maiese K
    World J Stem Cells; 2015 Aug; 7(7):999-1009. PubMed ID: 26328016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
    Maiese K
    Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.